The DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index.
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Open accessAbstract
Tumor cells increase the use of anabolic pathways to satisfy the metabolic requirements associated with a high growth rate. Transformed cells take up and metabolize nutrients such as glucose and glutamine at high levels that support anabolic growth. Oncogenic signaling through the PI3K/Akt and Myc pathways directly control glucose and glutamine uptake, respectively. In order to achieve elevated rates of nucleotide biosynthesis, neoplastic cells must divert carbon from PI3K/Akt-induced glycolytic flux into the nonoxidative branch of the pentose phosphate pathway to generate ribose-5-phosphate. This redirection of glucose catabolism appears to be regulated by cytoplasmic tyrosine kinases. Myc-induced glutamine metabolism also increases the abundance and activity of different rate-limiting enzymes that produce the molecular precursors required for de novo nucleotide synthesis. In this review, we will focus on recent progress in understanding how glucose and glutamine metabolism is redirected by oncogenes in order to support de novo nucleotide biosynthesis during proliferation and how metabolic reprogramming can be potentially exploited in the development of new cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cytosolic glutamine supports nucleotide biosynthesis, which is essential for rapidly proliferating cells30.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Self-citationHypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc882 · Cited by 1,658
Cited by
Sorted by citations
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,727
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2817 · Cited by 1,073
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism
Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C., Hill, C., Goddard, W. A., Peters, E. C., Driggers, E. M., & Hsieh‐Wilson, L. C. (2012) · Science · doi:10.1126/science.1222278 · Cited by 696
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 665
Glioblastoma: From Molecular Pathology to Targeted Treatment
Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130324 · Cited by 531
Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W.-M., & Phang, J. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203244109 · Cited by 483
Nucleotide metabolism: a pan-cancer metabolic dependency
Mullen, N. J., & Singh, P. K. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00557-7 · Cited by 502
Metabolic Regulation by p53 Family Members
Berkers, C. R., Maddocks, O. D. K., Cheung, E. C., Mor, I., & Vousden, K. H. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.019 · Cited by 458
B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease
Lyon, P. D., Strippoli, V., Fang, B., & Cimmino, L. (2020) · Nutrients · doi:10.3390/nu12092867 · Cited by 473
Masui, K., Tanaka, K., Akhavan, D., Babic, I., Gini, B., Matsutani, T., Iwanami, A., Liu, F., Villa, G. R., Gu, Y., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.013 · Cited by 407
Systemic elevation of PTEN induces a tumor-suppressive metabolic state
Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C. J., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.030 · Cited by 377
Wellen, K. E., Lu, C., Mancuso, A., Lemons, J. M. S., Ryczko, M., Dennis, J. W., Rabinowitz, J. D., Coller, H. A., & Thompson, C. B. (2010) · Genes & Development · doi:10.1101/gad.1985910 · Cited by 377
Self-citationMaddocks, O. D. K., & Vousden, K. H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0735-5 · Cited by 370
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
Wang, H., Nicolay, B. N., Chick, J. M., Gao, X., Geng, Y., Ren, H., Gao, H., Yang, G., Williams, J. A., Suski, J. M., et al. (2017) · Nature · doi:10.1038/nature22797 · Cited by 347
Anchorage-independent cell growth signature identifies tumors with metastatic potential
Mori, S., Chang, J. T., Andrechek, E. R., Matsumura, N., Baba, T., Yao, G., Kim, J., Gatza, M. L., Murphy, S. K., & Nevins, J. R. (2009) · Oncogene · doi:10.1038/onc.2009.139 · Cited by 354
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 316
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E. S., Sahu, U., & Ben‐Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 289
Signaling in Control of Cell Growth and MetabolismPreprint
Ward, P. S., & Thompson, C. B. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006783 · Cited by 289
Self-citationPathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 269
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
Montal, E. D., Dewi, R. E., Bhalla, K., Ou, L., Hwang, B. J., Ropell, A. E., Gordon, C. R., Liu, W.-J., DeBerardinis, R. J., Sudderth, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.025 · Cited by 261
Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Rao, X., Duan, X., Mao, W., Li, X., Li, Z., Li, Q., Zheng, Z., Xu, H., Chen, M., Wang, P. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9468 · Cited by 267
Tumor imaging using hyperpolarized 13 C magnetic resonance spectroscopy
Brindle, K. M., Bohndiek, S. E., Gallagher, F. A., & Kettunen, M. I. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22999 · Cited by 252
Romero‐Garcia, S., López-González, J. S., ́ez-Viveros, J. L. B., Aguilar‐Cázares, D., & Prado-Garcı́a, H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.11.18140 · Cited by 254
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234
Keller, K. E., Tan, I. S., & Lee, Y.-S. (2012) · Science · doi:10.1126/science.1224409 · Cited by 228
Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network
Goodwin, C. M., Xu, S., & Munger, J. C. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.08.007 · Cited by 227
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Liu, C., Yin, Q., Zhou, H., Wu, Y., Pu, J., Li, X., Liu, W., Huang, X. Y., Jiang, T., Wu, M., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 227
Cancer Cell MetabolismPreprint
Cairns, R. A., Harris, I. S., McCracken, S. A., & Mak, T. W. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.012856 · Cited by 229
Chen, Q., Kirk, K., Shurubor, Y. I., Zhao, D., Arreguin, A. J., Shahi, I., Valsecchi, F., Primiano, G., Calder, E. L., Carelli, V., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.002 · Cited by 210
Undercover: gene control by metabolites and metabolic enzymesPreprint
van der Knaap, J. A., & Verrijzer, C. P. (2016) · Genes & Development · doi:10.1101/gad.289140.116 · Cited by 222
The Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213
Herranz, D., Ambesi‐Impiombato, A., Sudderth, J., Sánchez-Martín, M., Belver, L., Tosello, V., Xu, L., Wendorff, A. A., Castillo-Martín, M., Haydu, J. E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3955 · Cited by 212
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
Wang, X., Yang, K., Xie, Q., Wu, Q., Mack, S. C., Shi, Y., Kim, L. J. Y., Prager, B. C., Flavahan, W. A., Liu, X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4537 · Cited by 206
Movahed, Z. G., Rastegari‐Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 214
Karunakaran, S. K., Ramachandran, S., Coothankandaswamy, V., Elangovan, S., Babu, E., Periyasamy‐Thandavan, S., Gurav, A., Gnana‐Prakasam, J. P., Singh, N., Schoenlein, P. V., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229518 · Cited by 202
Bohndiek, S. E., Kettunen, M. I., Hu, D., Kennedy, B. W. C., Boren, J., Gallagher, F. A., & Brindle, K. M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2045925 · Cited by 190
TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis
Cheung, E. C., Athineos, D., Lee, P., Ridgway, R. A., Lambie, W., Nixon, C., Strathdee, D., Blyth, K., Sansom, O. J., & Vousden, K. H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.001 · Cited by 192
Lukey, M. J., Greene, K. S., Erickson, J. W., Wilson, K. F., & Cerione, R. A. (2016) · Nature Communications · doi:10.1038/ncomms11321 · Cited by 190
NRF2: KEAPing Tumors Protected
Pillai, R., Hayashi, M., Zavitsanou, A.-M., & Papagiannakopoulos, T. Y. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0922 · Cited by 196
Cheng, Z., Huang, H., Li, M., Liang, X., Tan, Y., & Chen, Y. (2023) · Pharmaceuticals · doi:10.3390/ph16050644 · Cited by 194
MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism
Lee, C., Kim, K. H., & Cohen, P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.015 · Cited by 178
Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL
Li, B., Li, H., Bai, Y., Kirschner‐Schwabe, R., Yang, J. J. J., Chen, Y., Lü, G., Tzoneva, G., Ma, X., Wu, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3840 · Cited by 175
Maya‐Mendoza, A., Ostráková, J., Košař, M., Hall, A., Dušková, P., Mistrík, M., Merchut‐Maya, J. M., Hodný, Z., Bártková, J., Christensen, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 179
Molecular targeting of hypoxia in radiotherapy
Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 178
Targeting cancer metabolism – aiming at a tumour's sweet-spot
Jones, N. P., & Schulze, A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.017 · Cited by 164
The Proline Regulatory Axis and Cancer
Phang, J. M., Liu, W., Hancock, C. N., & Christian, K. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00060 · Cited by 164
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinomaPreprint
Dayton, T. L., Gocheva, V., Miller, K. M., Israelsen, W. J., Bhutkar, A. J., Clish, C. B., Davidson, S. M., Luengo, A., Bronson, R. T., Jacks, T., et al. (2016) · Genes & Development · doi:10.1101/gad.278549.116 · Cited by 154
Tong, X., Zhao, F., Mancuso, A., Gruber, J. J., & Thompson, C. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911316106 · Cited by 165
Self-citationSandulache, V. C., Ow, T. J., Pickering, C. R., Frederick, M. J., Zhou, G., Fokt, I., Davis‐Malesevich, M., Priebe, W., & Myers, J. N. (2011) · Cancer · doi:10.1002/cncr.25868 · Cited by 143
Cai, Z., Zhao, J., Li, J., Peng, D.-N., Wang, X., Chen, T.-L., Qiu, Y.-P., Chen, P.-P., Li, W.-J., Xu, L., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.000661 · Cited by 137
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 133
Regulation of nucleotide metabolism in cancers and immune disorders
Ali, E. S., & Ben‐Sahra, I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.003 · Cited by 137
The Impact of One Carbon Metabolism on Histone Methylation
Serefidou, M., Venkatasubramani, A. V., & Imhof, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00764 · Cited by 131
Tumor cell energy metabolism and its common features with yeast metabolism
Díaz-Ruiz, R., Uribe‐Carvajal, S., Devin, A., & Rigoulet, M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.003 · Cited by 133
Icard, P., & Lincet, H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.001 · Cited by 133
Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression
Chang, Y., Chan, Y.-C., Chang, W., Lin, Y., Yang, C., Su, C., Huang, M.-S., Wu, A. T. H., & Hsiao, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.001 · Cited by 123
Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
Masui, K., Tanaka, K., Ikegami, S., Villa, G. R., Yang, H., Yong, W. H., Cloughesy, T. F., Yamagata, K., Arai, N., Cavenee, W. K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511759112 · Cited by 123
Liu, R., Li, W., Tao, B., Wang, X., Yang, Z., Zhang, Y., Wang, C., Liu, R., Gao, H., Liang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08921-8 · Cited by 121
The regulation of cancer cell death and metabolism by extracellular matrix attachment
Buchheit, C. L., Rayavarapu, R. R., & Schafer, Z. T. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.04.007 · Cited by 115
Hyperpolarized [2-13C]-Fructose: A Hemiketal DNP Substrate for In Vivo Metabolic Imaging
Keshari, K. R., Wilson, D. M., Chen, A. P., Bok, R., Larson, P. E. Z., Hu, S., Criekinge, M. V., Macdonald, J. M., Vigneron, D. B., & Kurhanewicz, J. V. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9049355 · Cited by 121
Sun, W., Liu, Y., Glazer, C. A., Shao, C., Bhan, S., Demokan, S., Zhao, M., Rudek, M. A., Ha, P. K., & Califano, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2604 · Cited by 123
Micromanaging aerobic respiration and glycolysis in cancer cells
Orang, A., Petersen, J., McKinnon, R. A., & Michael, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.014 · Cited by 117
Nontargeted Elucidation of Metabolic Pathways Using Stable-Isotope Tracers and Mass Spectrometry
Hiller, K., Metallo, C. M., Kelleher, J. K., & Stephanopoulos, G. N. (2010) · Analytical Chemistry · doi:10.1021/ac1011574 · Cited by 107
Okazaki, A., Gameiro, P. A., Christodoulou, D. C., Laviolette, L. A., Schneider, M., Chaves, F. L., Stemmer-Rachamimov, A. O., Yazinski, S. A., Lee, R. E., Jr., Stephanopoulos, G. N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87800 · Cited by 110
Furtado, C. M., Marcondes, M. C., Sola‐Penna, M., de Souza, M. L. S., & Zancan, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030462 · Cited by 108
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Juvekar, A., Hu, H., Yadegarynia, S., Lyssiotis, C. A., Ullas, S., Lien, E. C., Bellinger, G., Son, J., Hok, R. C., Seth, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522223113 · Cited by 93
Alterations in cancer cell metabolism: The Warburg effect and metabolic adaptation
Asgari, Y., Zabihinpour, Z., Salehzadeh‐Yazdi, A., Schreiber, F., & Masoudi‐Nejad, A. (2015) · Genomics · doi:10.1016/j.ygeno.2015.03.001 · Cited by 98
Spoden, G. A., Rostek, U., Lechner, S. G., Mitterberger, M. C., Mazurek, S., & Zwerschke, W. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.024 · Cited by 95
APC/CCDH1 synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression
Li, Y., Yao, C.-F., Xu, F., Qu, Y., Li, J.-T., Lin, Y., Cao, Z., Lin, P., Xu, W., Zhao, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10375-x · Cited by 96
Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
Sobanski, T., Rose, M., Suraweera, A., O'Byrne, K. J., Richard, D. J., & Bolderson, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633305 · Cited by 86
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 88
A review of HPRT and its emerging role in cancer
Townsend, M. H., Robison, R. A., & O'Neill, K. L. (2018) · Medical Oncology · doi:10.1007/s12032-018-1144-1 · Cited by 87
The Intersection of Purine and Mitochondrial Metabolism in Cancer
Vitto, H. D., Arachchige, D., Richardson, B. C., & French, J. B. (2021) · Cells · doi:10.3390/cells10102603 · Cited by 89
The role of p53 in glucose metabolism
Cheung, E. C., & Vousden, K. H. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.006 · Cited by 88
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
Su, W. Y., Tian, L. Y., Guo, L. P., Huang, L., & Gao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188952 · Cited by 88
Mannava, S., Moparthy, K., Wheeler, L. J., Natarajan, V., Zucker, S. N., Fink, E. E., Im, M. M., Flanagan, S. A., Burhans, W. C., Zeitouni, N. C., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.011 · Cited by 85
Bhatia, B., Hsieh, M., Kenney, A. M., & Nahle, Z. A. (2010) · Oncogene · doi:10.1038/onc.2010.454 · Cited by 83
Sahu, D., Lotan, Y., Wittmann, B. M., Neri, B. P., & Hansel, D. E. (2017) · Cancer Medicine · doi:10.1002/cam4.1109 · Cited by 78
Metabolic regulation of neurodifferentiation in the adult brain
Maffezzini, C., Calvo‐Garrido, J., Wredenberg, A., & Freyer, C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03430-9 · Cited by 86
Mijatovic, T., & Robert Kiss, A. (2013) · Planta Medica · doi:10.1055/s-0032-1328243 · Cited by 77
The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 76
Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress
Cheng, K. W., Agarwal, R., Mitra, S., Lee, J., Carey, M. S., Gray, J. W., & Mills, G. B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100193 · Cited by 77
Energy metabolism in cancer cells: How to explain the Warburg and Crabtree effects?
Antone, P. D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.06.002 · Cited by 81
Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease
Buj, R., & Aird, K. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00177 · Cited by 76
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism
Jeong, S. M., & Haigis, M. C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0167 · Cited by 74
Huang, Y., Jin, Q., Su, M., Ji, F., Wang, N., Zhong, C., Jiang, Y., Liu, Y., Zhang, Z., Yang, J., et al. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0342-8 · Cited by 72
RetractedEvidence-Based ZHENG: A Traditional Chinese Medicine Syndrome
Su, S.-B., Lü, A., Li, S., & Jia, W. P. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/246538 · Cited by 70
TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
Angioni, R., Sánchez‐Rodríguez, R., Viola, A., & Molon, B. (2021) · Cancers · doi:10.3390/cancers13030401 · Cited by 73
Integrative metabonomics as potential method for diagnosis of thyroid malignancy
Tian, Y., Nie, X., Xu, S., Li, Y., Huang, T., Tang, H., & Wang, Y. (2015) · Scientific Reports · doi:10.1038/srep14869 · Cited by 68
Wang, Y., Yun, Y., Wu, B., Wen, L., Wen, M., Yang, H., Zhao, L., Liu, W., Huang, S., Wen, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10103 · Cited by 73
Metadata
- Authors
- Tong, X., Zhao, F., & Thompson, C. B.
- Affiliations
- Abramson Cancer Center (US)
- Corresponding author
- Tong, Xuemei
- Zhao, Fangping
- Thompson, Craig B
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 32-37
- ISSN
- 0959-437X (ISSN-L)
- PMC
- PMC2707261
- OpenAlex
- W2002869675
- Cited by
- 351
- References
- 56
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 22 · 2023: 20 · 2022: 22 · 2021: 24 · 2020: 32 · 2019: 20 · 2018: 18 · 2017: 15 · 2016: 17 · 2015: 26 · 2014: 17 · 2013: 15 · 2012: 33
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Genetics & Development (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA092660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, metabolic reprogramming, PI3K/Akt signaling, c-Myc, glucose metabolism, glutamine metabolism, pentose phosphate pathway, ribose-5-phosphate, glycolysis, oncogenic signaling, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glucose, Glutamine, Glycolysis, Humans, Models, Biological, Neoplasms, Pentose Phosphate Pathway, Ribosemonophosphates, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review